Variant report

Variant	esv3500491
Chromosome Location	chr15:40417175-40446353
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:200)
CpG islands
(count:794)
Chromatin interactive
region (count:16)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:200 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr15:40417275-40417528	H1-hESC	embryonic stem cell:	n/a	n/a
2	BHLHE40	chr15:40430005-40430254	K562	blood:	n/a	n/a
3	CBX3	chr15:40429853-40430262	K562	blood:	n/a	n/a
4	CCNT2	chr15:40430023-40430270	K562	blood:	n/a	n/a
5	CEBPB	chr15:40435736-40435900	K562	blood:	n/a	n/a
6	CEBPB	chr15:40443732-40444023	IMR90	lung:	n/a	n/a
7	CEBPB	chr15:40442382-40443011	IMR90	lung:	n/a	chr15:40442499-40442510 chr15:40442934-40442945
8	CEBPB	chr15:40443847-40443950	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr15:40443717-40444050	HepG2	liver:	n/a	n/a
10	CEBPB	chr15:40442828-40443031	K562	blood:	n/a	chr15:40442934-40442945
11	CEBPB	chr15:40443710-40444079	K562	blood:	n/a	n/a
12	CEBPB	chr15:40443743-40444006	A549	lung:	n/a	n/a
13	CEBPB	chr15:40424981-40425100	HepG2	liver:	n/a	n/a
14	CEBPB	chr15:40442356-40442674	Hela-S3	cervix:	n/a	chr15:40442499-40442510
15	CEBPB	chr15:40442901-40443053	Hela-S3	cervix:	n/a	chr15:40442934-40442945
16	CEBPB	chr15:40442815-40443020	HepG2	liver:	n/a	chr15:40442934-40442945
17	CEBPB	chr15:40443716-40444021	K562	blood:	n/a	n/a
18	CEBPB	chr15:40443816-40443974	K562	blood:	n/a	n/a
19	CEBPB	chr15:40446205-40446233	HepG2	liver:	n/a	chr15:40446221-40446232
20	CHD2	chr15:40417229-40417422	H1-hESC	embryonic stem cell:	n/a	n/a
21	CTBP2	chr15:40417230-40417460	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTCF	chr15:40429789-40430100	K562	blood:	n/a	n/a
23	CTCF	chr15:40429928-40430021	MCF-7	breast:	n/a	n/a
24	CTCF	chr15:40429746-40430217	HCT-116	colon:	n/a	n/a
25	CTCF	chr15:40429715-40430171	MCF-7	breast:	n/a	n/a
26	CTCF	chr15:40429944-40430019	MCF-7	breast:	n/a	n/a
27	CTCF	chr15:40429832-40429873	Pancreas_OC	pancreas:	n/a	n/a
28	CTCF	chr15:40429880-40430030	A549	lung:	n/a	n/a
29	CTCF	chr15:40429815-40430131	K562	blood:	n/a	n/a
30	CTCF	chr15:40429900-40430050	MCF-7	breast:	n/a	n/a
31	CTCF	chr15:40429843-40430103	H1-hESC	embryonic stem cell:	n/a	n/a
32	CTCF	chr15:40429940-40430090	NHEK	skin:	n/a	n/a
33	CTCF	chr15:40427179-40427252	Spleen_OC	spleen:	n/a	n/a
34	CTCF	chr15:40429756-40430136	H1-hESC	embryonic stem cell:	n/a	n/a
35	CTCF	chr15:40429880-40430030	HepG2	liver:	n/a	n/a
36	CTCF	chr15:40429881-40430065	MCF-7	breast:	n/a	n/a
37	CTCF	chr15:40429900-40430050	HEK293	kidney:	n/a	n/a
38	CTCF	chr15:40429880-40430030	K562	blood:	n/a	n/a
39	CTCF	chr15:40429880-40430030	HBMEC	blood vessel:	n/a	n/a
40	CTCF	chr15:40417297-40417305	MCF-7	breast:	n/a	n/a
41	CTCF	chr15:40429850-40430115	K562	blood:	n/a	n/a
42	CTCF	chr15:40429920-40430008	HepG2	liver:	n/a	n/a
43	CTCF	chr15:40429860-40430010	MCF-7	breast:	n/a	n/a
44	CTCF	chr15:40429860-40430010	K562	blood:	n/a	n/a
45	CTCF	chr15:40428546-40428577	GM20000	blood:	n/a	n/a
46	CTCF	chr15:40429871-40430059	K562	blood:	n/a	n/a
47	CTCF	chr15:40418370-40418618	H1-hESC	embryonic stem cell:	n/a	n/a
48	CTCF	chr15:40429924-40430026	NHEK	skin:	n/a	n/a
49	CTCF	chr15:40429919-40430022	H1-hESC	embryonic stem cell:	n/a	n/a
50	CTCF	chr15:40417256-40417268	MCF-7	breast:	n/a	n/a

(count:794 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:40422219-40422269	U87	brain:	n/a
2	chr15:40422219-40422269	U87	brain:	n/a
3	chr15:40423298-40423348	HCT-116	colon:	n/a
4	chr15:40423445-40423495	HEK293	kidney:	embryo
5	chr15:40426006-40426056	AG09319	gingival:	n/a
6	chr15:40422098-40422148	HCPEpiC	choroid plexus:	n/a
7	chr15:40421135-40421185	NHBE	bronchial:	n/a
8	chr15:40426006-40426056	HPAEpiC	pulmonary alveolar:	n/a
9	chr15:40417564-40417614	SK-N-SH_RA	brain:	n/a
10	chr15:40422098-40422148	AG09309	skin:	n/a
11	chr15:40421135-40421185	HCPEpiC	choroid plexus:	n/a
12	chr15:40417564-40417614	ovcar-3	ovarian:	n/a
13	chr15:40417564-40417614	U87	brain:	n/a
14	chr15:40417564-40417614	A549	lung:	n/a
15	chr15:40423556-40423606	U87	brain:	n/a
16	chr15:40426006-40426056	GM19239	blood:	n/a
17	chr15:40417564-40417614	IMR90	lung:	fetal
18	chr15:40422098-40422148	PFSK-1	brain:	n/a
19	chr15:40426063-40426113	LNCaP	prostate:	n/a
20	chr15:40423445-40423495	PFSK-1	brain:	n/a
21	chr15:40421005-40421055	HIPEpiC	eye:	n/a
22	chr15:40443853-40443903	AG10803	skin:	n/a
23	chr15:40426063-40426113	HNPCEpiC	eye:	n/a
24	chr15:40443853-40443903	Hepatocyte	liver:	n/a
25	chr15:40421135-40421185	HRPEpiC	eye:	n/a
26	chr15:40422219-40422269	HAEpiC	amniotic membrane:	n/a
27	chr15:40423445-40423495	NH-A	brain:	n/a
28	chr15:40422098-40422148	IMR90	lung:	fetal
29	chr15:40426006-40426056	NHBE	bronchial:	n/a
30	chr15:40421080-40421130	SKMC	muscle:	n/a
31	chr15:40421080-40421130	SK-N-SH_RA	brain:	n/a
32	chr15:40423445-40423495	HIPEpiC	eye:	n/a
33	chr15:40417564-40417614	NT2-D1	testis:	n/a
34	chr15:40423298-40423348	PANC-1	pancreas:	n/a
35	chr15:40426006-40426056	BE2_C	brain:	n/a
36	chr15:40423298-40423348	HRCEpiC	kidney:	n/a
37	chr15:40417564-40417614	HAEpiC	amniotic membrane:	n/a
38	chr15:40421135-40421185	A549	lung:	n/a
39	chr15:40421135-40421185	HPAEpiC	pulmonary alveolar:	n/a
40	chr15:40421135-40421185	ProgFib	skin:	n/a
41	chr15:40426006-40426056	NB4	blood:	n/a
42	chr15:40422098-40422148	SKMC	muscle:	n/a
43	chr15:40425922-40425972	HMEC	breast:	n/a
44	chr15:40422219-40422269	HNPCEpiC	eye:	n/a
45	chr15:40422098-40422148	MCF10A-Er-Src	breast:	n/a
46	chr15:40425922-40425972	PrEC	prostate:	n/a
47	chr15:40422219-40422269	Caco-2	colon:	n/a
48	chr15:40422098-40422148	HNPCEpiC	eye:	n/a
49	chr15:40422219-40422269	HCM	heart:	n/a
50	chr15:40443853-40443903	HNPCEpiC	eye:	n/a

(count:16 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr15:40440789..40442524-chr15:40442904..40444462,2	K562	blood:
2	chr15:40396612..40398136-chr15:40423980..40425844,2	K562	blood:
3	chr15:40437357..40438931-chr15:40442265..40443877,2	K562	blood:
4	chr15:40440789..40442524-chr15:40442904..40444462,2	K562	blood:
5	chr15:40423124..40425673-chr15:40427954..40430256,2	K562	blood:
6	chr15:40433017..40434874-chr15:40436940..40438586,2	MCF-7	breast:
7	chr15:40389070..40391081-chr15:40419316..40421072,2	K562	blood:
8	chr15:40437357..40438931-chr15:40442265..40443877,2	K562	blood:
9	chr15:40441619..40443769-chr15:40446969..40449341,2	K562	blood:
10	chr15:40388597..40390833-chr15:40440085..40442294,2	K562	blood:
11	chr15:40423124..40425673-chr15:40427954..40430256,2	K562	blood:
12	chr15:40446320..40448068-chr15:40456241..40458639,2	K562	blood:
13	chr15:40433017..40434874-chr15:40436940..40438586,2	MCF-7	breast:
14	chr15:40397083..40397632-chr15:40429201..40430196,2	MCF-7	breast:
15	chr15:40441619..40444532-chr15:40445691..40448469,3	K562	blood:
16	chr15:40441619..40444532-chr15:40445691..40448469,3	K562	blood:

No data

Variant related genes	Relation type
ENSG00000259239	TF binding region
ENSG00000259239	CpG island

Extended variants
information (count: 865 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:865 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs548337897	chr15:40417176-40417177	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs62019996	chr15:40417193-40417194	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs117530295	chr15:40417205-40417206	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs58216655	chr15:40417236-40417237	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs537174349	chr15:40417311-40417312	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs58902242	chr15:40417337-40417338	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs2447227	chr15:40417399-40417400	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs486944	chr15:40417427-40417428	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs185274348	chr15:40417466-40417467	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs150862082	chr15:40417478-40417479	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs139305734	chr15:40417488-40417489	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs190427735	chr15:40417532-40417533	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs182595276	chr15:40417543-40417544	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs577218190	chr15:40417549-40417550	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs113216726	chr15:40417551-40417552	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs369201711	chr15:40417583-40417584	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs572255009	chr15:40417614-40417615	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs376458289	chr15:40417628-40417629	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs188793113	chr15:40417636-40417637	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs547373983	chr15:40417646-40417647	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs141011388	chr15:40417673-40417674	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs371297084	chr15:40417675-40417676	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs368016494	chr15:40417679-40417680	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs397770978	chr15:40417681-40417682	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs553515738	chr15:40417682-40417683	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs57599926	chr15:40417686-40417687	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs149997567	chr15:40417687-40417688	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs550026811	chr15:40417688-40417689	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs191432934	chr15:40417693-40417694	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs529408250	chr15:40417711-40417712	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs549319195	chr15:40417712-40417713	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs565944129	chr15:40417753-40417754	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs535299483	chr15:40417755-40417756	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs551673746	chr15:40417769-40417770	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs184121406	chr15:40417773-40417774	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs59793325	chr15:40417793-40417794	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs557181244	chr15:40417813-40417814	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs576080560	chr15:40417855-40417856	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs73392641	chr15:40417864-40417865	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs543304502	chr15:40417866-40417867	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs555311939	chr15:40417872-40417873	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs376704993	chr15:40417898-40417899	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs144343850	chr15:40417917-40417918	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs563282064	chr15:40417998-40417999	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs112630037	chr15:40418000-40418001	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs371050530	chr15:40418020-40418021	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs113336480	chr15:40418025-40418026	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs80249577	chr15:40418039-40418040	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs188581298	chr15:40418076-40418077	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs565741205	chr15:40418087-40418088	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
HDAC8	0	CNVD
NIPBL	0	CNVD
RAD21	0	CNVD
SMC1A	0	CNVD
SMC3	0	CNVD
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Angelman syndrome	16183798	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16774939	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	21785460	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	17053054	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Cancer	20164920	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Cancer	21129771	CNVD
Breast cancer	21045282	CNVD
Papillary thyroid carcinoma	22161024	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	22032731	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Pancreatic cancer	17952125	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	22150418	CNVD
Autosomal-recessive limb girdle muscular dystrophy	22150418	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:205 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:40402000-40418600	Weak transcription	Right Atrium	heart
2	chr15:40415200-40418000	Enhancers	H1 Cell Line	embryonic stem cell
3	chr15:40416400-40417800	Enhancers	Placenta	Placenta
4	chr15:40416400-40418600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
5	chr15:40416600-40417800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
6	chr15:40416600-40417800	Enhancers	NHEK	skin
7	chr15:40416600-40418000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
8	chr15:40416600-40418000	Enhancers	iPS-15b Cell Line	embryonic stem cell
9	chr15:40416600-40418000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr15:40416600-40418600	Enhancers	H9 Cell Line	embryonic stem cell
11	chr15:40416600-40418800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
12	chr15:40416800-40417200	Enhancers	ES-I3 Cell Line	embryonic stem cell
13	chr15:40416800-40417200	Enhancers	HUES64 Cell Line	embryonic stem cell
14	chr15:40416800-40417600	Enhancers	HMEC	breast
15	chr15:40416800-40417800	Enhancers	Placenta Amnion	Placenta Amnion
16	chr15:40417000-40417200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
17	chr15:40417000-40417200	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
18	chr15:40417000-40417400	Active TSS	HUES48 Cell Line	embryonic stem cell
19	chr15:40417000-40417400	Active TSS	HUES6 Cell Line	embryonic stem cell
20	chr15:40417000-40417600	Active TSS	iPS-20b Cell Line	embryonic stem cell
21	chr15:40417000-40417800	Enhancers	Pancreas	Pancrea
22	chr15:40417000-40418000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
23	chr15:40417200-40417400	Enhancers	iPS-18 Cell Line	embryonic stem cell
24	chr15:40417200-40417400	Enhancers	Breast Myoepithelial Primary Cells	Breast
25	chr15:40417200-40417600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
26	chr15:40417200-40417600	Active TSS	HUES64 Cell Line	embryonic stem cell
27	chr15:40417400-40417600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
28	chr15:40417400-40417600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
29	chr15:40417400-40417600	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
30	chr15:40417600-40417800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
31	chr15:40417600-40418000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
32	chr15:40417600-40418000	Enhancers	HUES48 Cell Line	embryonic stem cell
33	chr15:40417600-40418000	Enhancers	HUES6 Cell Line	embryonic stem cell
34	chr15:40417600-40418000	Enhancers	HUES64 Cell Line	embryonic stem cell
35	chr15:40417600-40418000	Enhancers	iPS-18 Cell Line	embryonic stem cell
36	chr15:40417800-40418600	Enhancers	iPS-20b Cell Line	embryonic stem cell
37	chr15:40418400-40418600	Enhancers	Rectal Mucosa Donor 29	rectum
38	chr15:40418600-40418800	Enhancers	Rectal Mucosa Donor 31	rectum
39	chr15:40418600-40419400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
40	chr15:40419400-40419600	Enhancers	iPS-20b Cell Line	embryonic stem cell
41	chr15:40421200-40421400	Bivalent Enhancer	K562	blood
42	chr15:40427000-40429600	Enhancers	HSMMtube	muscle
43	chr15:40427200-40427400	Enhancers	HUES64 Cell Line	embryonic stem cell
44	chr15:40427200-40427600	Enhancers	H9 Cell Line	embryonic stem cell
45	chr15:40427200-40429200	Enhancers	HSMM	muscle
46	chr15:40427400-40427600	Enhancers	HUES6 Cell Line	embryonic stem cell
47	chr15:40427400-40429000	Weak transcription	HUES64 Cell Line	embryonic stem cell
48	chr15:40427600-40429000	Weak transcription	HUES6 Cell Line	embryonic stem cell
49	chr15:40427600-40429200	Weak transcription	H9 Cell Line	embryonic stem cell
50	chr15:40428000-40428800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links